Logo image of ARE

ALEXANDRIA REAL ESTATE EQUIT (ARE) Stock Fundamental Analysis

NYSE:ARE - New York Stock Exchange, Inc. - US0152711091 - REIT - Currency: USD

76.92  +0.65 (+0.85%)

After market: 77.77 +0.85 (+1.11%)

Fundamental Rating

3

ARE gets a fundamental rating of 3 out of 10. The analysis compared the fundamentals against 130 industry peers in the Diversified REITs industry. While ARE is still in line with the averages on profitability rating, there are concerns on its financial health. ARE is valied quite expensively at the moment, while it does show a decent growth rate. ARE also has an excellent dividend rating.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

ARE had positive earnings in the past year.
In the past year ARE had a positive cash flow from operations.
ARE had positive earnings in each of the past 5 years.
In the past 5 years ARE always reported a positive cash flow from operatings.
ARE Yearly Net Income VS EBIT VS OCF VS FCFARE Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2B -4B -6B

1.2 Ratios

ARE's Return On Assets of 0.35% is in line compared to the rest of the industry. ARE outperforms 45.38% of its industry peers.
ARE has a Return On Equity (0.75%) which is comparable to the rest of the industry.
The Return On Invested Capital of ARE (1.99%) is worse than 66.92% of its industry peers.
The Average Return On Invested Capital over the past 3 years for ARE is in line with the industry average of 3.16%.
The 3 year average ROIC (1.88%) for ARE is below the current ROIC(1.99%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA 0.35%
ROE 0.75%
ROIC 1.99%
ROA(3y)0.84%
ROA(5y)1.54%
ROE(3y)1.65%
ROE(5y)2.98%
ROIC(3y)1.88%
ROIC(5y)1.79%
ARE Yearly ROA, ROE, ROICARE Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 2 -2 4 6

1.3 Margins

ARE's Profit Margin of 4.07% is in line compared to the rest of the industry. ARE outperforms 50.77% of its industry peers.
In the last couple of years the Profit Margin of ARE has declined.
ARE has a Operating Margin of 27.83%. This is comparable to the rest of the industry: ARE outperforms 60.00% of its industry peers.
ARE's Operating Margin has been stable in the last couple of years.
ARE has a better Gross Margin (71.54%) than 65.38% of its industry peers.
ARE's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 27.83%
PM (TTM) 4.07%
GM 71.54%
OM growth 3Y6.37%
OM growth 5Y0.87%
PM growth 3Y-28.91%
PM growth 5Y-16.02%
GM growth 3Y0.65%
GM growth 5Y0.27%
ARE Yearly Profit, Operating, Gross MarginsARE Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 40 60

1

2. Health

2.1 Basic Checks

With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), ARE is destroying value.
Compared to 1 year ago, ARE has about the same amount of shares outstanding.
Compared to 5 years ago, ARE has more shares outstanding
The debt/assets ratio for ARE is higher compared to a year ago.
ARE Yearly Shares OutstandingARE Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 50M 100M 150M
ARE Yearly Total Debt VS Total AssetsARE Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10B 20B 30B

2.2 Solvency

ARE has a Debt/Equity ratio of 0.72. This is a neutral value indicating ARE is somewhat dependend on debt financing.
The Debt to Equity ratio of ARE (0.72) is better than 76.15% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Altman-Z N/A
ROIC/WACC0.35
WACC5.65%
ARE Yearly LT Debt VS Equity VS FCFARE Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 5B -5B 10B 15B

2.3 Liquidity

ARE has a Current Ratio of 0.24. This is a bad value and indicates that ARE is not financially healthy enough and could expect problems in meeting its short term obligations.
ARE has a Current ratio of 0.24. This is amonst the worse of the industry: ARE underperforms 87.69% of its industry peers.
A Quick Ratio of 0.24 indicates that ARE may have some problems paying its short term obligations.
Looking at the Quick ratio, with a value of 0.24, ARE is doing worse than 86.92% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.24
Quick Ratio 0.24
ARE Yearly Current Assets VS Current LiabilitesARE Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B

4

3. Growth

3.1 Past

ARE shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -28.97%.
ARE shows a very negative growth in Earnings Per Share. Measured over the last years, the EPS has been decreasing by -10.24% yearly.
The Revenue has been growing slightly by 5.93% in the past year.
Measured over the past years, ARE shows a quite strong growth in Revenue. The Revenue has been growing by 16.12% on average per year.
EPS 1Y (TTM)-28.97%
EPS 3Y-21.98%
EPS 5Y-10.24%
EPS Q2Q%-107.22%
Revenue 1Y (TTM)5.93%
Revenue growth 3Y15.22%
Revenue growth 5Y16.12%
Sales Q2Q%-1.64%

3.2 Future

ARE is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 0.33% yearly.
ARE is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 2.20% yearly.
EPS Next Y6.05%
EPS Next 2Y16.87%
EPS Next 3Y0.33%
EPS Next 5YN/A
Revenue Next Year-2.33%
Revenue Next 2Y0.16%
Revenue Next 3Y-0.05%
Revenue Next 5Y2.2%

3.3 Evolution

The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
ARE Yearly Revenue VS EstimatesARE Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 1B 2B 3B
ARE Yearly EPS VS EstimatesARE Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 0 2 4 6

1

4. Valuation

4.1 Price/Earnings Ratio

Based on the Price/Earnings ratio of 101.21, the valuation of ARE can be described as expensive.
Based on the Price/Earnings ratio, ARE is valued a bit more expensive than 60.00% of the companies in the same industry.
ARE is valuated expensively when we compare the Price/Earnings ratio to 27.45, which is the current average of the S&P500 Index.
The Price/Forward Earnings ratio is 31.29, which means the current valuation is very expensive for ARE.
ARE's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. ARE is cheaper than 74.62% of the companies in the same industry.
ARE is valuated rather expensively when we compare the Price/Forward Earnings ratio to 21.90, which is the current average of the S&P500 Index.
Industry RankSector Rank
PE 101.21
Fwd PE 31.29
ARE Price Earnings VS Forward Price EarningsARE Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 20 40 60 80 100

4.2 Price Multiples

Based on the Enterprise Value to EBITDA ratio, ARE is valued a bit cheaper than 70.00% of the companies in the same industry.
Industry RankSector Rank
P/FCF N/A
EV/EBITDA 12.03
ARE Per share dataARE EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 20 40 60 80 100

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates ARE does not grow enough to justify the current Price/Earnings ratio.
PEG (NY)16.73
PEG (5Y)N/A
EPS Next 2Y16.87%
EPS Next 3Y0.33%

7

5. Dividend

5.1 Amount

ARE has a Yearly Dividend Yield of 7.11%, which is a nice return.
ARE's Dividend Yield is a higher than the industry average which is at 6.64.
Compared to an average S&P500 Dividend Yield of 2.42, ARE pays a better dividend.
Industry RankSector Rank
Dividend Yield 7.11%

5.2 History

The dividend of ARE is nicely growing with an annual growth rate of 6.07%!
ARE has been paying a dividend for at least 10 years, so it has a reliable track record.
ARE has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)6.07%
Div Incr Years14
Div Non Decr Years14
ARE Yearly Dividends per shareARE Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

691.78% of the earnings are spent on dividend by ARE. This is not a sustainable payout ratio.
ARE's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP691.78%
EPS Next 2Y16.87%
EPS Next 3Y0.33%
ARE Yearly Income VS Free CF VS DividendARE Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 -2B -4B -6B
ARE Dividend Payout.ARE Dividend Payout, showing the Payout Ratio.ARE Dividend Payout.PayoutRetained Earnings

ALEXANDRIA REAL ESTATE EQUIT

NYSE:ARE (7/3/2025, 7:02:34 PM)

After market: 77.77 +0.85 (+1.11%)

76.92

+0.65 (+0.85%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)04-28 2025-04-28/amc
Earnings (Next)07-21 2025-07-21/amc
Inst Owners97.64%
Inst Owner Change-0.66%
Ins Owners1.1%
Ins Owner Change13.26%
Market Cap13.31B
Analysts72.22
Price Target99.45 (29.29%)
Short Float %3.72%
Short Ratio3.59
Dividend
Industry RankSector Rank
Dividend Yield 7.11%
Yearly Dividend5.22
Dividend Growth(5Y)6.07%
DP691.78%
Div Incr Years14
Div Non Decr Years14
Ex-Date06-30 2025-06-30 (1.32)
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-125.69%
Min EPS beat(2)-141.07%
Max EPS beat(2)-110.31%
EPS beat(4)1
Avg EPS beat(4)-78.61%
Min EPS beat(4)-141.07%
Max EPS beat(4)6.08%
EPS beat(8)2
Avg EPS beat(8)-74.93%
EPS beat(12)4
Avg EPS beat(12)-28.32%
EPS beat(16)6
Avg EPS beat(16)-17.17%
Revenue beat(2)0
Avg Revenue beat(2)-2.62%
Min Revenue beat(2)-3.14%
Max Revenue beat(2)-2.09%
Revenue beat(4)1
Avg Revenue beat(4)-2.3%
Min Revenue beat(4)-4.16%
Max Revenue beat(4)0.18%
Revenue beat(8)4
Avg Revenue beat(8)-0.7%
Revenue beat(12)8
Avg Revenue beat(12)8.1%
Revenue beat(16)12
Avg Revenue beat(16)13.26%
PT rev (1m)-8.81%
PT rev (3m)-16.31%
EPS NQ rev (1m)3.44%
EPS NQ rev (3m)-18.83%
EPS NY rev (1m)5%
EPS NY rev (3m)-41.74%
Revenue NQ rev (1m)0.92%
Revenue NQ rev (3m)-0.4%
Revenue NY rev (1m)0.69%
Revenue NY rev (3m)-1.04%
Valuation
Industry RankSector Rank
PE 101.21
Fwd PE 31.29
P/S 4.13
P/FCF N/A
P/OCF 9.7
P/B 0.76
P/tB 0.77
EV/EBITDA 12.03
EPS(TTM)0.76
EY0.99%
EPS(NY)2.46
Fwd EY3.2%
FCF(TTM)-6.12
FCFYN/A
OCF(TTM)7.93
OCFY10.31%
SpS18.63
BVpS100.96
TBVpS99.34
PEG (NY)16.73
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 0.35%
ROE 0.75%
ROCE 2.52%
ROIC 1.99%
ROICexc 2.02%
ROICexgc 2.03%
OM 27.83%
PM (TTM) 4.07%
GM 71.54%
FCFM N/A
ROA(3y)0.84%
ROA(5y)1.54%
ROE(3y)1.65%
ROE(5y)2.98%
ROIC(3y)1.88%
ROIC(5y)1.79%
ROICexc(3y)1.91%
ROICexc(5y)1.83%
ROICexgc(3y)1.93%
ROICexgc(5y)1.85%
ROCE(3y)2.37%
ROCE(5y)2.27%
ROICexcg growth 3Y14.19%
ROICexcg growth 5Y1.72%
ROICexc growth 3Y14.6%
ROICexc growth 5Y2.01%
OM growth 3Y6.37%
OM growth 5Y0.87%
PM growth 3Y-28.91%
PM growth 5Y-16.02%
GM growth 3Y0.65%
GM growth 5Y0.27%
F-Score5
Asset Turnover0.09
Health
Industry RankSector Rank
Debt/Equity 0.72
Debt/FCF N/A
Debt/EBITDA 5.8
Cap/Depr 193.33%
Cap/Sales 75.39%
Interest Coverage 5.64
Cash Conversion 63.67%
Profit Quality N/A
Current Ratio 0.24
Quick Ratio 0.24
Altman-Z N/A
F-Score5
WACC5.65%
ROIC/WACC0.35
Cap/Depr(3y)392.1%
Cap/Depr(5y)533.59%
Cap/Sales(3y)146.17%
Cap/Sales(5y)201.48%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-28.97%
EPS 3Y-21.98%
EPS 5Y-10.24%
EPS Q2Q%-107.22%
EPS Next Y6.05%
EPS Next 2Y16.87%
EPS Next 3Y0.33%
EPS Next 5YN/A
Revenue 1Y (TTM)5.93%
Revenue growth 3Y15.22%
Revenue growth 5Y16.12%
Sales Q2Q%-1.64%
Revenue Next Year-2.33%
Revenue Next 2Y0.16%
Revenue Next 3Y-0.05%
Revenue Next 5Y2.2%
EBIT growth 1Y4.51%
EBIT growth 3Y22.56%
EBIT growth 5Y17.14%
EBIT Next Year177.35%
EBIT Next 3Y42.24%
EBIT Next 5Y33.84%
FCF growth 1Y67.5%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-2.66%
OCF growth 3Y14.2%
OCF growth 5Y17.08%